ONTORPACEPT
UNII Q8A4U1Z9N2

Substance Identification & Data

This profile provides standardized clinical and technical data for Ontorpacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q8A4U1Z9N2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2131089-46-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Q8A4U1Z9N2
CAS Registry Number
2131089-46-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ONTORPACEPT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10927
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ontorpacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ONTORPACEPT

Common Names & Synonyms

1-118-SIGNAL REGULATORY PROTEIN .ALPHA. (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN FC FRAGMENT), DIMER
HUMAN SIGNAL-REGULATORY PROTEIN ALPHA (SIRP.ALPHA., TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1, INHIBITORY RECEPTOR SHPS-1), (L14>S, T20>S, T22>I, R24>H, A27>V, G45>A, D65>E, L66>S, N70>E, R77>S, G79>S, D101>DEL, V102>T101)-VARIANT, N-TERMINAL (1-118)-FRAGMENT (BINDING DOMAIN FOR CD47 (INHIBITOR OF PHAGOCYTOSIS BYMACROPHAGES)), FUSED TO A HUMAN IMMUNOGLOBULIN G1 C-TERMINAL FCFRAGMENT (119-345), DIMER
ONTORPACEPT [INN]
ONTORPACEPT [WHO-DD]